BUY Ajanta Pharma Limited — Prabhudas Lilladher
byPrabhudas LilladherHorizon: NA (inferred 1 year)31 Jul 2026via Moneycontrol Broker Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Ajanta Pharma Shares Rise 2% as Q1 Profit Reaches Rs 334 Crore
NewsGoogle News·14 Aug · 3d ago
3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·10 Aug · 1w ago
Q1 Results Today Highlights: Swiggy narrows loss, Bajaj Finance, M&M, Gillette, Vedanta, Vedanta Aluminium, Ajanta Pharma, IRFC, ICRA, Niva Bupa profit rise, Hyundai PAT down; Torrent Pharma PAT up 3.3%; Tata Steel profit jumps 19%, NSDL's PAT up 9%
NewsHbl·30 Jul · 2w ago
Dividend Alert: Ajanta Pharma Announces Interim Dividend — Check Record Date, Payout Date
NewsNdtv-Profit·30 Jul · 2w ago
Ajanta Pharma Q1 profit jumps 31% on strong US sales; declares ₹32 dividend
NewsCnbc-Tv18·30 Jul · 2w ago
Ajanta Pharma షేర్ ధర పడిపోయింది.. కారణం ఇదే!
NewsGoogle News·5 Aug · 2w ago
Ajanta Pharma Share: डिविडेंड रिकॉर्ड डेट पर **3%** गिरा शेयर, जानिए क्या है वजह
NewsGoogle News·5 Aug · 2w ago
Ajanta Pharma Share Price: डिव्हिडंडमुळे शेअर पडला 3%, पण ही आहे खरी बातमी!
NewsGoogle News·5 Aug · 2w ago
Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%
NewsLivemint·24 Jul · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

